Keywords: roche, oral, anti-cmv, prodrug, approved, been, granted

Roche's oral anti-CMV prodrug approved

Article | 05 April 2001

Print This

Roche has been granted approval by the US Food and Drug Administrationfor its oral prescription drug Valcyte (valganciclovir), to treat ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in